Literature DB >> 11146652

The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin.

J M Bellanger1, C Astier, C Sardet, Y Ohta, T P Stossel, A Debant.   

Abstract

Rho GTPases control actin reorganization and many other cellular functions. Guanine nucleotide-exchange factors (GEFs) activate Rho GTPases by promoting their exchange of GDP for GTP. Trio is a unique Rho GEF, because it has separate GEF domains, GEFD1 and GEFD2, that control the GTPases RhoG/Rac1 and RhoA, respectively. Dbl-homology (DH) domains that are common to GEFs catalyse nucleotide exchange, and pleckstrin-homology (PH) domains localize Rho GEFs near their downstream targets. Here we show that Trio GEFD1 interacts through its PH domain with the actin-filament-crosslinking protein filamin, and localizes with endogenous filamin in HeLa cells. Trio GEFD1 induces actin-based ruffling in filamin-expressing, but not filamin-deficient, cells and in cells transfected with a filamin construct that lacks the Trio-binding domain. In addition, Trio GEFD1 exchange activity is not affected by filamin binding. Our results indicate that filamin, as a molecular target of Trio, may be a scaffold for the spatial organization of Rho-GTPase-mediated signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11146652     DOI: 10.1038/35046533

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  88 in total

1.  Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling.

Authors:  Qize Wei; Robert S Adelstein
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

Review 2.  Filamins in mechanosensing and signaling.

Authors:  Ziba Razinia; Toni Mäkelä; Jari Ylänne; David A Calderwood
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

Review 3.  The integrin-actin connection, an eternal love affair.

Authors:  Cord Brakebusch; Reinhard Fässler
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

4.  Identification of a novel sequence in PDZ-RhoGEF that mediates interaction with the actin cytoskeleton.

Authors:  Jayashree Banerjee; Philip B Wedegaertner
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

5.  Kalirin Dbl-homology guanine nucleotide exchange factor 1 domain initiates new axon outgrowths via RhoG-mediated mechanisms.

Authors:  Victor May; Martin R Schiller; Betty A Eipper; Richard E Mains
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

6.  Trio is a key guanine nucleotide exchange factor coordinating regulation of the migration and morphogenesis of granule cells in the developing cerebellum.

Authors:  Ya-Jing Peng; Wei-Qi He; Jing Tang; Tao Tao; Chen Chen; Yun-Qian Gao; Wen-Cheng Zhang; Xue-Yan He; Yu-Yuan Dai; Nian-Chun Zhu; Ning Lv; Cheng-Hai Zhang; Yan-Ning Qiao; Li-Ping Zhao; Xiang Gao; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

7.  Plasma membrane association of p63 Rho guanine nucleotide exchange factor (p63RhoGEF) is mediated by palmitoylation and is required for basal activity in cells.

Authors:  Mohamed Aittaleb; Akiyuki Nishimura; Maurine E Linder; John J G Tesmer
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 8.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

Review 9.  Filamin structure, function and mechanics: are altered filamin-mediated force responses associated with human disease?

Authors:  Andrew J Sutherland-Smith
Journal:  Biophys Rev       Date:  2011-01-27

10.  Functional analysis of the Caenorhabditis elegans UNC-73B PH domain demonstrates a role in activation of the Rac GTPase in vitro and axon guidance in vivo.

Authors:  Terrance J Kubiseski; Joe Culotti; Tony Pawson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.